Reliability and validity of the Japaneseversion of the Agitated Behaviour in Dementia Scale in Alzheimer's disease : three dimensions of agitated behaviour in dementia
Reliability and validity of the Japaneseversion of the Agitated Behaviour in Dementia Scale in Alzheimer's disease : three dimensions of agitated behaviour in dementia
复制标题
日本版阿尔茨海默病痴呆症激越行为量表的信度和效度：痴呆症激越行为的三个维度
DOI：
10.1111/j.1479-8301.2011.00371.x
复制
发表时间：
2011
期刊：
影响因子：
2
通讯作者：
Torii Katsuyoshi
中科院分区：
文献类型：
--
作者：
辰巳 寛;山本 正彦;仲秋秀太郎;波多野 和夫;中野敬子;村松健司;中野敬子;黄正国・兒玉憲一;Torii Katsuyoshi
背景：痴呆症患者的情绪激动不仅严重影响患者的生活质量，也严重影响照顾者的生活质量。因此，对痴呆症患者的激动行为进行适当的评估对于临床治疗是必要的。编制了《痴呆症激越行为量表》(ABID)日文版，对其信度和效度进行了检验，并进行了因子分析，以阐明其因子结构。然后检验ABID日文版的内部一致性、重测信度和同时效度。结果：日文版ABID在频率等级(Cronbach‘sα=0.89)和反应等级(Cronbach’sα=0.92)上均具有良好的内部信度，在频率等级和反应等级上具有良好的重测信度。ABID频率评分总分与Cohen-Mansfield激越问卷(CMAI)显著相关，ABID反应评分总分与Zarit Burden访谈显著相关。因子分析结果显示：躯体激越行为、言语激越行为和精神症状是三种亚型。结论：日文版ABID可用于评估AD患者的激越行为。重要的是，了解这些激越行为的亚型可能会对个体化治疗计划产生影响。
Background:Agitation in dementia seriously affects not only patients' quality of life (QOL), but also caregivers' QOL. Thus, an appropriate assessment of agitated behaviour in dementia is needed for clinical management. We developed the Japanese version of the Agitated Behaviour in Dementia scale (ABID), examined its reliability and validity, and carried out its factor analysis to elucidate its factor structure.Methods:The Japanese version of the ABID was given caregivers of 149 Japanese patients with Alzheimer's disease (AD). The internal‐consistency, test–retest reliability and concurrent validity of the Japanese version of the ABID were then examined. A factor analysis was used to examine the agitated behavioural dimensions underlying ABID.Results:The Japanese version of the ABID showed an excellent internal reliability for both frequency ratings (Cronbach's α= 0.89) and reaction ratings (Cronbach's α= 0.92), and an excellent test–retest reliability for both frequency ratings and reaction ratings. The total score for the frequency ratings of the ABID was significantly associated with the Cohen‐Mansfield Agitation Inventory (CMAI), and the total score for the reaction ratings of the ABID was significantly associated with the Zarit Burden Interview. The factor analysis showed three subtypes: physically agitated behaviour, verbally agitated behaviour and psychosis symptoms.Conclusions:The Japanese version of the ABID promises to be useful for assessing agitated behaviour in patients with AD. Importantly, understanding these subtypes of agitated behaviour might have implications for individualized treatment plans.